Vivo Surgical is a patient-centric, clinically-driven medical device developer and manufacturer headquartered in Singapore. Operating in over 20 international territories, the company is at the forefront of developing a state-of-the-art endoscopic surgical robot designed for complex endoluminal procedures in the gastrointestinal tract. With ISO 13485 certification and international accreditations including the US FDA and European CE mark, Vivo Surgical is positioned to address global medical needs through innovative applications of science and technology. Established in 2018, the company's proprietary technologies span in vivo surgical LED lighting, portable endoscopy, and flexible endoscopic robotics. The latest investment, a funding round investment on 01 April 2022, was secured from Mount Sinai Innovation Partners, signaling confidence in Vivo Surgical's potential to lead advancements in the field of surgical technology and robotics.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Funding Round | Unknown | 1 | Mount Sinai Innovation Partners | 01 Apr 2022 |
No recent news or press coverage available for Vivo Surgical.